Results 81 to 90 of about 8,807 (99)

Combining an anti-HER2 antibody-drug conjugate with an anti-nectin-4 antibody-drug conjugate enhances efficacy in breast cancer and gastric cancer models. [PDF]

Cancer Cell Int
Yazdi N, Pourjamal N, Li H, Laakkonen P, Joensuu H, Barok M.   +5 more
europepmc   +1 more source

Staging metastatic urothelial cancer with Nectin-4 imaging using Gallium-68-N188 PET/CT. [PDF]

BJU Int
Miederer M, Pretze M, Abbate E, Hartig A, do Mar Ferreira Machado J, Böhm K, Sommer U, Hoberück S, Bundschuh RA, Kotzerke J, Thomas C.   +10 more
europepmc   +1 more source

Nectin-4-Targeting Radiotracers: Novel Theranostic Agents for Precision Oncology in Cancer. [PDF]

Mol Diagn Ther
Speltri G, Badrane I, Napolitano R, Boschi A, Uccelli L, Filippi L, Guidoboni M, Brunelli M, Lancia F, Martini P, Iudicello A, Cittanti C, Bartolomei M, Urso L.   +13 more
europepmc   +1 more source

METTL3-mediated m ⁶A modification facilitates Nectin-4-induced VNN1 upregulation and promotion of ESCC progression. [PDF]

Acta Biochim Biophys Sin (Shanghai)
Long Y, Yang H, Zhang R, Zhao Q, Yang M, Song G, Liu K.   +6 more
europepmc   +1 more source

ETx-22, a Novel Nectin-4-Directed Antibody-Drug Conjugate, Demonstrates Safety and Potent Antitumor Activity in Low-Nectin-4-Expressing Tumors. [PDF]

Cancer Res Commun
Lopez M, Crompot E, Josselin E, Farina A, Rubis M, Castellano R, Fares J, Wehbe M, Collette Y, Charafe E, Blanchin S, Romagne F, Pálfi A, Hechler T, Pahl A, Azim HA, Lhospice F, Mamessier E, Bertucci F, Elands J, Préville X, Olive D.   +21 more
europepmc   +1 more source

Spatial distribution and subtype-specific expression patterns of Nectin-4 in muscle-invasive bladder cancer. [PDF]

BJU Int
Olah C, Sichward L, Hadaschik B, Darr C, Grünwald V, Krafft U, Grünwald BT, Mahmoud O, Al-Nader M, Nyirady P, Reis H, Szarvas T.   +11 more
europepmc   +1 more source

Impact of Membranous Nectin-4 on Outcomes of Platinum-Based Chemotherapy in Metastatic Urothelial Carcinoma. [PDF]

Cancers (Basel)
Hsueh FJ, Wang CC, Guo JC, Chueh SC, Tsai YC.   +4 more
europepmc   +1 more source

"Precision on Two Wheels"─Structural Refinement of ⁶⁴Cu- and ⁶⁸Ga-Labeled Bicyclic Peptides Targeting Nectin-4 for Improved Tumor Imaging: From Preclinical Development to First-in-Human Application. [PDF]

J Med Chem
Krönke T, Trommer J, Ullrich M, Laube M, Löser R, Kretzschmar J, Urbanova M, Stadlbauer S, Brandt F, Platzek I, Hoberück S, Kotzerke J, Thomas C, Miederer M, Bundschuh RA, Kopka K, Pietzsch J, Wodtke R.   +17 more
europepmc   +1 more source

[⁶⁴Cu]Cu-NOTA-EV-F(ab')₂ Enables Same-Day Immuno-PET Imaging of Nectin-4 in Triple-Negative Breast and Urothelial Bladder Cancers. [PDF]

J Nucl Med
Huang W, Li L, Chao F, Yang Q, Mixdorf JC, Engle JW, Hsu JC, Kang L, Cai W.   +8 more
europepmc   +1 more source

²²⁵Ac/⁸⁹Zr-Labeled N4MU01 Radioimmunoconjugates as Theranostics Against Nectin-4-Positive Triple-Negative Breast Cancer. [PDF]

J Nucl Med
Babeker H, Njotu FN, Pougoue Ketchemen J, Monzer A, Tikum AF, Doroudi A, Nwangele E, Uppalapati M, Fonge H.   +8 more
europepmc   +1 more source